BioIntelliSense Archives - Medical Design Sourcing

At-home predictive care and the shifting patient experience

The eMed platform connects patients with telehealth providers for home testing. [Photo courtesy of eMed]

These medtech developers are advancing remote patient monitoring, virtual care, and AI predictive care.

Robin Farmanfarmaian

The combination of remote patient monitoring (RPM), virtual care and AI predictive care is changing the patient experience. Instead of the occasional clinic visit, people can interact with their healthcare daily and on-demand.

Here are a few of the medtech startups advancing remote, continuous and predictive care. Together, these companies enable truly personalized care, tailored to someone in their daily life and environment.

Remote patient monitoring (RPM)

There are many technology devices that have cleared the FDA and qualify as remote physiologic monitoring under the Medicare CPT codes. Medicare also has remote therapeutic monitoring CPT codes for musculoskeletal …

BioIntellisense acquires AlertWatch to expand patient monitoring portfolio

BioIntelliSense announced today that it acquired AlertWatch, an FDA-cleared patient monitoring platform.

AlertWatch offers integration, data analysis and a patented display of contextual patient data to help in clinical decision-making.

BioIntelliSense in August partnered with Medtronic on the distribution of patient monitoring technology. Through this partnership, it intends to distribute AlertWatch to hospitals throughout the U.S. AlertWatch is now a new offering in the Medtronic HealthCast portfolio.

“The addition of AlertWatch offers healthcare providers comprehensive continuous monitoring solutions, and an accelerated path from adoption to full scale utilization,” said Dr. James Mault, founder and CEO of BioIntelliSense. “The patented AlertWatch multi-parameter interface displays and analyzes data from inpatient vitals, the electronic medical record (EMR), laboratory systems and BioIntelliSense medical-grade wearables, to provide clinical intelligen…

Medtronic, BioIntelliSense partner on distribution of wearable patient monitoring device

The BioButton from BioIntelliSense

Medtronic (NYSE:MDT) announced today that it partnered with BioIntelliSense on distribution rights for the BioButton device.

BioButton, a multi-paremter wearable for continuous, connected monitoring, measures up to 1,440 vital sign measurements per day. Its measurements include skin temperature, respiratory rate at rest, and heart rate at rest.

The device, combined with advanced analytics, helps clinicians to better detect early signs of patient deterioration. Conversely, it can help to identify stable patients who may be candidates for earlier hospital discharge.

BioIntelliSense’s rechargeable device also offers configurable acute and post-acute modes, according to a news release. These modes help to continuously monitor patients transitioning from higher to lower acuity settings.

The partnership enables the Medtronic patient monitoring business to offer access to a medical grade device that provides conti…

Philips launches new face scanning tech, partners with BioIntelliSense on telehealth

Royal Philips (NYSE:PHG) today announced two separate steps toward helping patients receive remote care as telehealth’s importance continues to grow.

Amsterdam-based Philips said today that it launched its Philips Respironics mask selector 3D facial scanning system for fitting masks and formed a strategic collaboration with BioIntelliSense to monitor at-risk patients from the hospital into the home.

The company touts its Respironics mask selector as the first and only clinically validated solution of its kind, as it helps providers fit nine of 10 patients with the right mask from the start, offering help in the shift toward digitized healthcare and reduced costs associated with fitting time and mask waste.

Using 3D camera technology, scans with the system capture 150 frames and 15 million points of facial geography data. Philips’ algorithm identifies the 46,200 data points most critical to providing an accurate and precise mask recommendation…